110353 (2025)

: It is classified as a Schedule III controlled substance due to the presence of codeine. Mechanism of Action

: Crushing, chewing, or snorting the extended-release product can lead to an uncontrolled delivery of codeine, which may result in a fatal overdose. 110353

: Because opioids can cause significant constipation, bowel function should be routinely monitored. Patients are often encouraged to increase fluid and fiber intake or use stimulant laxatives if treatment exceeds 2–3 days. Contraindications and Risks : It is classified as a Schedule III

: Antihistamine combined with an opioid agonist. 110353